Advertisement
FORM vs VRNA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FORM is a Buy and VRNA is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FORM’s FA Score shows that 0 FA rating(s) are green whileVRNA’s FA Score has 1 green FA rating(s).
- FORM’s FA Score: 0 green, 5 red.
- VRNA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FORM’s TA Score shows that 5 TA indicator(s) are bullish while VRNA’s TA Score has 6 bullish TA indicator(s).
- FORM’s TA Score: 5 bullish, 5 bearish.
- VRNA’s TA Score: 6 bullish, 4 bearish.
Price Growth
FORM (@Semiconductors) experienced а -1.85% price change this week, while VRNA (@Biotechnology) price change was +12.17% for the same time period.
The average weekly price growth across all stocks in the @Semiconductors industry was -0.49%. For the same industry, the average monthly price growth was +8.85%, and the average quarterly price growth was +4.98%.
The average weekly price growth across all stocks in the @Biotechnology industry was +5.74%. For the same industry, the average monthly price growth was +2.75%, and the average quarterly price growth was +0.73%.
Reported Earning Dates
FORM is expected to report earnings on Jul 30, 2025.
VRNA is expected to report earnings on Jul 31, 2025.
Industries' Descriptions
@Semiconductors (-0.49% weekly)The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.
@Biotechnology (+5.74% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| FORM | VRNA | FORM / VRNA | |
| Capitalization | 2.42B | 7.22B | 33% |
| EBITDA | 116M | -121.41M | -96% |
| Gain YTD | -28.727 | 82.623 | -35% |
| P/E Ratio | 45.45 | N/A | - |
| Revenue | 766M | 119M | 644% |
| Total Cash | 299M | 401M | 75% |
| Total Debt | 37.5M | 244M | 15% |
FORM | VRNA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 61 | 20 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 83 Overvalued | |
PROFIT vs RISK RATING 1..100 | 82 | 3 | |
SMR RATING 1..100 | 81 | 95 | |
PRICE GROWTH RATING 1..100 | 80 | 34 | |
P/E GROWTH RATING 1..100 | 38 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FORM's Valuation (70) in the Electronic Production Equipment industry is in the same range as VRNA (83) in the Pharmaceuticals Other industry. This means that FORM’s stock grew similarly to VRNA’s over the last 12 months.
VRNA's Profit vs Risk Rating (3) in the Pharmaceuticals Other industry is significantly better than the same rating for FORM (82) in the Electronic Production Equipment industry. This means that VRNA’s stock grew significantly faster than FORM’s over the last 12 months.
FORM's SMR Rating (81) in the Electronic Production Equipment industry is in the same range as VRNA (95) in the Pharmaceuticals Other industry. This means that FORM’s stock grew similarly to VRNA’s over the last 12 months.
VRNA's Price Growth Rating (34) in the Pharmaceuticals Other industry is somewhat better than the same rating for FORM (80) in the Electronic Production Equipment industry. This means that VRNA’s stock grew somewhat faster than FORM’s over the last 12 months.
FORM's P/E Growth Rating (38) in the Electronic Production Equipment industry is somewhat better than the same rating for VRNA (100) in the Pharmaceuticals Other industry. This means that FORM’s stock grew somewhat faster than VRNA’s over the last 12 months.
| FORM | VRNA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 1 day ago 74% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 69% | 1 day ago 82% |
| MACD ODDS (%) | 1 day ago 65% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 71% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 77% | 1 day ago 82% |
| Advances ODDS (%) | 1 day ago 73% | 1 day ago 79% |
| Declines ODDS (%) | 13 days ago 70% | 14 days ago 83% |
| BollingerBands ODDS (%) | 1 day ago 71% | 1 day ago 76% |
| Aroon ODDS (%) | 1 day ago 76% | 1 day ago 85% |
Advertisement
FORM and
Correlation & Price change
A.I.dvisor indicates that over the last year, FORM has been closely correlated with KLAC. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if FORM jumps, then KLAC could also see price increases.
| Ticker / NAME | Correlation To FORM | 1D Price Change % | ||
|---|---|---|---|---|
| FORM | 100% | +4.46% | ||
| KLAC - FORM | 79% Closely correlated | +1.75% | ||
| VECO - FORM | 78% Closely correlated | +4.45% | ||
| KLIC - FORM | 78% Closely correlated | +2.34% | ||
| ENTG - FORM | 77% Closely correlated | +5.02% | ||
| AMAT - FORM | 77% Closely correlated | +2.84% | ||
More | ||||
VRNA and
Correlation & Price change
A.I.dvisor indicates that over the last year, VRNA has been loosely correlated with COGT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VRNA jumps, then COGT could also see price increases.
| Ticker / NAME | Correlation To VRNA | 1D Price Change % | ||
|---|---|---|---|---|
| VRNA | 100% | +0.84% | ||
| COGT - VRNA | 40% Loosely correlated | +3.21% | ||
| ROIV - VRNA | 39% Loosely correlated | +0.67% | ||
| TRDA - VRNA | 39% Loosely correlated | +1.23% | ||
| ZYME - VRNA | 39% Loosely correlated | +3.78% | ||
| CRNX - VRNA | 39% Loosely correlated | +0.69% | ||
More | ||||